Template:Available forms of progesterone

From blackwiki
Revision as of 07:33, 20 October 2020 by imported>Monkbot (→‎top: Task 17 (BRFA trial): replace to-be-deprecated: |name-list-format= (2× replaced; usage: 2 of 2);)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Available forms of progesterone[sources 1][lower-alpha 1]

Route Form Dose Brand name Availability[lower-alpha 2]
Oral Capsule 100, 200, 300 mg Prometrium[lower-alpha 3] Widespread
Tablet (SR) 200, 300, 400 mg Dubagest SR[lower-alpha 3] India
Sublingual Tablet 10, 25, 50, 100 mg Luteina[lower-alpha 3] Europe[lower-alpha 4]
Transdermal Gel[lower-alpha 5] 1% (25 mg) Progestogel Europe
Vaginal Capsule 100, 200 mg Utrogestan Widespread
Tablet 100 mg Endometrin[lower-alpha 3] Widespread
Gel 4, 8% (45, 90 mg) Crinone[lower-alpha 3] Widespread
Suppository 200, 400 mg Cyclogest Europe
Ring 10 mg/day[lower-alpha 6] Fertiring[lower-alpha 3] South America[lower-alpha 7]
Rectal Suppository 200, 400 mg Cyclogest Europe
Uterine IUD 38 mg Progestasert Discontinued
Intramuscular
injection 		Oil solution 2, 5, 10, 20, 25,
50, 100 mg/mL		 Proluton[lower-alpha 3] Widespread
Aq. susp. 12.5, 30, 100 mg/mL Agolutin[lower-alpha 3] Europe[lower-alpha 8]
Emulsion 5, 10, 25 mg/mL Di-Pro-Emulsion Discontinued
Microsph. 20, 100 mg/mL ProSphere[lower-alpha 3] Mexico
Subcutaneous Aq. soln. (inj.) 25 mg/vial Prolutex Europe
Implant 50, 100 mg Proluton[lower-alpha 3] Discontinued
Intravenous Aq. soln. (inj.) 20 mg/mL Primolut Discontinued
Sources and footnotes:
  1. ↑ Sources: [1][2][3][4][5][6][7][8][9][10][11]
  1. ↑ This table only includes products where progesterone is the sole active ingredient.
  2. ↑ See also: Progesterone (medication) § Availability
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 Other brand names exist.
  4. ↑ Specifically in Poland and Ukraine.
  5. ↑ For local application to the breasts; negligible systemic effect.
  6. ↑ One progesterone vaginal ring provides 10mg of progesterone each day for 3 months.
  7. ↑ Specifically in Chile, Ecuador, and Peru.
  8. ↑ Specifically the Czech Republic and Slovakia.
Template documentation

See also

References

  1. ↑ "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 26 July 2018.
  2. ↑ Engel J, Kleemann A, Kutscher B, Reichert D (14 May 2014). Pharmaceutical Substances, 5th Edition, 2009: Syntheses, Patents and Applications of the most relevant APIs. Thieme. pp. 1145–. ISBN 978-3-13-179275-4.
  3. ↑ Becker, Kenneth L. (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 2168–. ISBN 978-0-7817-1750-2. Unknown parameter |name-list-style= ignored (help)
  4. ↑ Anita MV, Jain S, Goel N (31 July 2018). Use of Progestogens in Clinical Practice of Obstetrics and Gynecology. JP Medical Ltd. pp. 4–. ISBN 978-93-5270-218-3.
  5. ↑ Sauer, Mark V. (1 March 2013). Principles of Oocyte and Embryo Donation. Springer Science & Business Media. pp. 7, 117–118. ISBN 978-1-4471-2392-7. Unknown parameter |name-list-style= ignored (help)
  6. ↑ Elder K, Dale B (2 December 2010). In-Vitro Fertilization. Cambridge University Press. pp. 26–. ISBN 978-1-139-49285-0.
  7. ↑ https://web.archive.org/web/20191230051017/https://mx.prvademecum.com/medicamento/prosphere-11003/
  8. ↑ Heinrich Kahr (8 March 2013). Konservative Therapie der Frauenkrankheiten: Anzeigen, Grenzen und Methoden Einschliesslich der Rezeptur. Springer-Verlag. pp. 21–. ISBN 978-3-7091-5694-0.
  9. ↑ Basic Sex Hormone Therapy. Schering A.G. 1962. p. 96.
  10. ↑ Current Medicine and Drugs. 1962. p. 40. Primolut Intravenous (Schering A.G. Berlin)
  11. ↑ Haleem S, Khan MI (March 2015). "Changing Indian Market Trends of NMP: A Review" (PDF). International Journal of Pharma Research & Review. 4 (3): 28–30. ISSN 2278-6074.
Retrieved from "https://blackwiki.org/index.php?title=Template:Available_forms_of_progesterone&oldid=2427667"